InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Huizinga Robert Bindert, Vice-Président Exécutif. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 6 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €161k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Huizinga Robert Bindert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,500 shares0Common StockSEC:0001628280-22-005118:0
95,000 shares@ US$3.2046.9% of flowCommon StockSEC:0001628280-21-020527:0
16,000 shares@ US$2.636.4% of flowCommon StockSEC:0001628280-21-019051:0
5,000 shares@ US$19.8315.0% of flowCommon StockSEC:0001628280-21-018595:0
5,000 shares@ US$18.3013.8% of flowCommon StockSEC:0001628280-21-018218:0
40,000 shares@ US$3.0217.8% of flowCommon StockSEC:0001628280-21-009847:0
6 of 6 declarations
About Huizinga Robert Bindert
Robert Bindert Huizinga is the Executive Vice President of Research at Aurinia Pharmaceuticals Inc., a biopharmaceutical company. He is responsible for leading research and development initiatives aimed at innovating in the field of medical treatments.
